BPC-157 vs TB-500

The two most-researched tissue-repair peptides. Here is how the two research peptides compare on class, format and price.

BPC-157

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protein found in gastric juice. It is supplied as a lyophilised (freeze-dried) powder in a 10 mg vial for laboratory and in-vitro research use only.

In published research models BPC-157 is studied for its interaction with angiogenic and growth-factor signalling, and for its effects on connective-tissue and gastrointestinal repair pathways. It is frequently paired with TB-500 in comparative research.

TB-500

TB-500 is a synthetic peptide corresponding to the active region of Thymosin beta-4, a naturally occurring regenerative protein. It is supplied lyophilised in a 10 mg vial for laboratory and in-vitro research use only.

TB-500 is studied for its role in actin regulation, cell migration and angiogenesis in repair models, and is commonly compared with, and combined with, BPC-157 in connective-tissue research.

Which do researchers choose?

BPC-157 and TB-500 are the two most-researched tissue-repair peptides. The right choice depends on the research question: they differ in class (Pentadecapeptide (Body Protection Compound-157) vs Thymosin beta-4 fragment) and strength (10 mg vs 10 mg). Both are supplied lyophilised, third-party HPLC tested, and shipped express post Australia-wide for laboratory and in-vitro research use only.

Frequently asked questions